Galecto Inc. Files 2025 Proxy Statement
Ticker: DMRA · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1800315
Sentiment: neutral
Topics: proxy-statement, corporate-governance, annual-meeting
TL;DR
Galecto's proxy statement is in, shareholders vote soon on board and company direction.
AI Summary
Galecto, Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for the fiscal year ending December 31, 2024. The filing concerns the company's annual meeting and related corporate governance matters. Key individuals like Lori Firmani, Garrett Winslow, and Hans T. Schambye, MD PhD, are listed as members, with their roles likely related to board or committee appointments.
Why It Matters
This filing provides shareholders with essential information regarding the company's leadership, voting procedures, and executive compensation, enabling informed participation in corporate decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial distress or significant operational changes.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the financial information in the proxy statement.)
- 20250430 — Filing Date (The date the definitive proxy statement was submitted to the SEC.)
Key Players & Entities
- Galecto, Inc. (company) — Registrant
- Lori Firmani (person) — Member
- Garrett Winslow (person) — Member
- Hans T. Schambye, MD PhD (person) — Member
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on director nominations, executive compensation, and other corporate governance matters.
Who are the key individuals mentioned in the filing as members?
Key individuals mentioned as members are Lori Firmani, Garrett Winslow, and Hans T. Schambye, MD PhD.
What is Galecto, Inc.'s fiscal year end?
Galecto, Inc.'s fiscal year end is December 31.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on April 30, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 by Lori Firmani regarding Galecto, Inc. (DMRA).